Capturing structure and dynamics of transmembrane signaling proteins
Project Number5R01GM141298-03
Former Number1R01GM141298-01
Contact PI/Project LeaderPOGORELOV, TARAS V.
Awardee OrganizationUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Description
Abstract Text
Project Summary
To sense the environment, cells rely on membrane-embedded receptors. The receptor tyrosine kinase (RTK)
family of signaling proteins is large, diverse, and centrally important both to human development diseases and
cancers. Evidence so far supports a model that signal passage through RTKs is initiated by a structural change
in the extracellular domain and then conducted through the transmembrane (TMD) and juxtamembrane (JMD)
domains to the cytoplasmic kinase domain. The receptors usually are activated in the dimer form. Numerous
RTK mutations confer diseases, e.g. single point mutations in ~30% of residues of the TMD of the fibroblast
growth factor receptor 3 (FGFR3) are pathogenic, while mutations of tropomyosin receptor kinase A can lead
to cancers. Understanding the structural interactions of the FGFR3 and TrkA signaling TMD and JMD therefore
is crucial for fundamental biology and for future development of therapies that may target these pathways.
Atomistically resolved TMD+JMD dimer structures are the major objective of this project. Application of
traditional computational and crystallographic methods is hindered by the fluid nature of the membrane
environment. Our goal is to develop novel efficient computational methods that guide and maximally leverage
NMR, FRET, and in-cell experimental data and apply these methods to capture the FGFR3 and TrkA TMD and
TMD+JMD dimer structures for the wild type and mutated pathogenic forms. In Aim 1, we will combine our
novel highly mobile membrane mimetic model, capable of spontaneously capturing candidate TMD dimer
structures, with a novel minimally biased way of applying a reduced number of computational restraints based
on experimental distance measurements. The resulting TMD dimer structures will be validated by comparing
computed and experimentally measured parameters. These structures will reveal the role mutations play in
RTK dynamics. In Aim 2, we will use our computational-experimental approach to determine the role that
juxtamembrane domains play in RTK signaling. The resolved structures of the mutated dimers will facilitate
understanding of the pathology and mechanisms of receptor activation. Our novel computational approaches
combined with extended expertise of co-investigators and collaborators in NMR, FRET, RTK signaling, and
membrane-associated phenomena, uniquely position us to develop and apply this methodology. We will also
develop an open-source, user friendly workflow plugin for a widely-used software suite that will allow efficient
use of the proposed protocols by the scientific community. Completion of the specific aims will increase our
ability to efficiently gain structural information on RTKs and will open new research avenues for investigating
mechanisms of transmembrane signaling in health and disease leading to development of new treatments.
Public Health Relevance Statement
PROJECT NARRATIVE
Disorders of cell signaling cascades are known to cause developmental pathologies, inflammation,
diabetes, and cancers, while the mechanisms of signaling in health and disease are not well understood.
Transmembrane and juxtamembrane domains of the structurally diverse receptor tyrosine kinases are
central to the signal passage into the cell and numerous point mutations of these domains are attributed
to diseases, yet structures of their dimers are lacking. Our goals are to develop a versatile method that
combines novel computational approaches with experimental data, and to capture long-overdue dynamic
dimer structures of the wild type and the pathogenic mutated forms of representative receptor tyrosine
kinase subfamilies, improving our understanding of the mechanisms of cell signaling in disease and
leading to new treatments.
No Sub Projects information available for 5R01GM141298-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM141298-03
Patents
No Patents information available for 5R01GM141298-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM141298-03
Clinical Studies
No Clinical Studies information available for 5R01GM141298-03
News and More
Related News Releases
No news release information available for 5R01GM141298-03
History
No Historical information available for 5R01GM141298-03
Similar Projects
No Similar Projects information available for 5R01GM141298-03